Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early life antibiotic use and the risk of asthma and asthma exacerbations in children.
Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Turner S, Devereux G, Arabkhazaeli A, Soares P, Mukhopadhyay S, Garssen J, Palmer CNA, de Jongste JC, Jaddoe VWV, Duijts L, van Meel ER, Kraneveld AD, Maitland-van der Zee AH. Ahmadizar F, et al. Among authors: de jongste jc, de boer a. Pediatr Allergy Immunol. 2017 Aug;28(5):430-437. doi: 10.1111/pai.12725. Epub 2017 Jun 8. Pediatr Allergy Immunol. 2017. PMID: 28423467
Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors.
Maitland-van der Zee AH, Klungel OH, Stricker BH, Monique Verschuren WM, Kastelein JJ, Leufkens HG, de Boer A. Maitland-van der Zee AH, et al. Among authors: de boer a. Atherosclerosis. 2002 Aug;163(2):213-22. doi: 10.1016/s0021-9150(01)00725-0. Atherosclerosis. 2002. PMID: 12052467 Review.
Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men.
Maitland-van der Zee AH, Klungel OH, Stricker BH, Veenstra DL, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, van Duijn CM, de Boer A. Maitland-van der Zee AH, et al. Among authors: de boer a. Pharmacogenetics. 2004 Jan;14(1):53-60. doi: 10.1097/00008571-200401000-00006. Pharmacogenetics. 2004. PMID: 15128051
[Genetic variations affect drug safety and efficacy].
Harmsze AM, Deneer VH, Maitland-van der Zee AH, de Boer A, Klungel OH. Harmsze AM, et al. Among authors: de boer a. Ned Tijdschr Geneeskd. 2010;154:A1503. Ned Tijdschr Geneeskd. 2010. PMID: 20699026 Review. Dutch.
1,377 results